USPTO 2015–2025 USPTO PatentsView US Corporation

Atrion Medical Products, Inc.

USPTO PatentsView assignee record - 13 granted patents across 8 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Atrion ranks #20,785 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 8 technology areas.

#20,785
of 49,997 US assignees by volume
Top 42%
by Innovation Score (37.9/100)
17.5
avg claims per patent
+40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20785 · US Corporation #20,785 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #20,785/49,997
  • PHOTO-FINISH Atec International…
  • CPC-NARROW A61M · 8 areas
  • INNOV-THIN 37.9/100
  • CLAIMS-RICH 17.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +40% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Atec International Team Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Atrion’s 37.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Atrion

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Atrion's Innovation Score is 37.9/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Atrion?

Each dot is one of Atrion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Atrion’s own 17.5 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Atrion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 0510152025 Granted patents (volume) Avg claims / patent Atec International Team Co., Ltd. - 13, 11.15Atec Internationa…Athletes FOR Christ, LP - 13, 1Athletes FOR Chri…Athoc, Inc. - 13, 20.46AthocAtos France - 13, 21.62Atos FranceAurelia Holdings, LLC - 13, 1Aurelia HoldingsAurora Insight, Inc. - 13, 9.38Aurora InsightAvalyn Pharma Inc. - 13, 13.69Avalyn PharmaAvio S.P.A. - 13, 13.85Avio S P AAtrion Medical Products, Inc. - 13, 17.46Atrion Medical Pr…
Atrion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Atrion's grants concentrate

Atrion Medical Products, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 69.2% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2020. By volume, Atrion sits between Atec International Team Co., Ltd. and Avio S.P.A..

Atrion's three-year grant acceleration

Atrion Medical Products, Inc. shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Atrion's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Atrion holds 13 patents at rank #20,734, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Atrion

By rank, the assignees closest to #20,734 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Atrion's primary technology class.

Atrion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2016201920202021202320242025 1
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Atrion Medical Products, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 3 23.1%
2019 2 15.4%
2020 1 7.7%
2021 1 7.7%
2023 1 7.7%
2024 4 30.8%
2025partial year 1 7.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Atrion Medical Products, Inc.'s patent record in context - here's where to go next.

  • Atrion Medical Products, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 69.2% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #20,785 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Atrion Medical Products, Inc. against Atec International Team Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.